Inorganic Nitrite to Enhance Benefits From Exercise Training in Heart Failure With Preserved Ejection Fraction (HFpEF)

Trial Profile

Inorganic Nitrite to Enhance Benefits From Exercise Training in Heart Failure With Preserved Ejection Fraction (HFpEF)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2018

At a glance

  • Drugs Sodium nitrite (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms INABLE; INABLE-Training
  • Most Recent Events

    • 15 Aug 2018 The drug route, form has been changed from inhalation solution to oral capsules. The dosage of the drug has also been changed to 40 mg taken every 4 hours or 3 times per day during waking hours for 10 weeks.
    • 15 Aug 2018 Planned number of patients changed from 68 to 100.
    • 13 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top